Sam Altman, the CEO of OpenAI, revealed that they are considering developing a medical ChatGPT. Altman also expressed a desire to discuss the current robotics projects OpenAI is observing with Korean corporations.
CEO Altman attended the 'Builder Lab' developer workshop held at the The Plaza Hotel in Jung-gu, Seoul on the 4th. Altman explained, 'We are in the process of ensuring compliance with HIPAA for corporate products because we want medical groups to be able to use all OpenAI products,' and added, 'The medical field is one of the most anticipated areas because we can accelerate scientific innovation, save many lives, and do good work.'
Altman continued, 'We have a great interest in robotics, and the reason for visiting Korea is to see if local corporations are interested in this field,' and noted, 'Korea is an interesting place as it plays an important role in the AI ecosystem from semiconductors to energy.'
Altman also said, 'We see the importance of open-source models that can be utilized across various devices like PCs and plan to establish related strategies.' Altman explained regarding the DeepSic AI model, 'We are in the process of establishing response strategies.' Recently, DeepSic, a Chinese AI developer, has created a low-cost, high-performance AI model, raising concerns about a potential crisis for OpenAI.
It was reported that around 100 people, including major figures from large domestic corporations and IT developers, attended the event.
On the same day, CEO Altman also met with Chey Tae-won, the chairman of SK Group, in the morning. The meeting was attended by about 10 others, including Ryu Young-sang, CEO of SK Telecom, Kwak Noh-jung, CEO of SK hynix, and Kim Joo-sun, SK hynix AI Infrastructure president. Chey previously met Altman during a visit to OpenAI's headquarters last June during a business trip to the U.S.